label: Evaluate changes in respiratory and cardiac status (e.g., new-onset wheezing, hemoptysis, dyspnea, tachypnea, tachycardia, syncope) as patients who experience PE or DVT are at a higher risk of recurrence
label_lc: evaluate changes in respiratory and cardiac status (e.g., new-onset wheezing, hemoptysis, dyspnea, tachypnea, tachycardia, syncope) as patients who experience pe or dvt are at a higher risk of recurrence